Acquisitions14 Aug 2025, 08:31 pm
Sudarshan Pharma Industries to Acquire Assets from Srigen Lifesciences for Rs. 25.50 Crores
AI Summary
Sudarshan Pharma Industries Ltd. has approved the acquisition of land, building, and plant and machinery from Srigen Lifesciences Private Limited. The total sale consideration is Rs. 25.50 Crores for a total admeasuring area of 1,563.15 Square meters located at Plot nos. D-22, IDA-Medchal, Medchal Mandal, Malkajigiri District, Telangana. The acquisition will enable Sudarshan Pharma to enlarge its production capabilities and acquire potential API key starting materials with viable commercial technology and patent rights held by Srigen Lifesciences.
Key Highlights
- Sudarshan Pharma Industries to acquire assets from Srigen Lifesciences for Rs. 25.50 Crores
- The acquisition includes land, building, and plant and machinery
- Total admeasuring area of 1,563.15 Square meters located at Plot nos. D-22, IDA-Medchal, Medchal Mandal, Malkajigiri District, Telangana
- Acquisition will enable Sudarshan Pharma to enlarge its production capabilities
- Srigen Lifesciences has developed 50 potential API key starting materials with viable commercial technology and patent rights